Gheorghe Fundueanu | Drug Delivery Systems | Best Researcher Award

Dr. Gheorghe Fundueanu | Drug Delivery Systems | Best Researcher Award

Scientist at Institutul de chimie macromoleculara “Petru Poni” | Romania

Dr. Gheorghe Fundueanu is a senior researcher and Head of the Department of Natural Polymers, Bioactive and Biocompatible Materials at the “Petru Poni” Institute of Macromolecular Chemistry, Romanian Academy, Iassy, Romania. He is a recognized expert in polymer science, focusing on the design of smart polymeric materials for biomedical use. With decades of experience, his work integrates drug delivery systems, biomimetic hydrogels, and polymer-based therapeutics. His multidisciplinary approach includes in vitro and in vivo evaluations, advancing translational biomedical research. He has significantly contributed to the development of pharmaceutical formulations and has earned national and international recognition for his impactful scientific contributions.

Publication Profile 

Google Scholar

Education 

Dr. Gheorghe Fundueanu obtained his M.Sc. in Chemistry with a focus on macromolecular compounds from “Al. I. Cuza” University, Iassy, Romania. He pursued his Ph.D. in Chemistry at the “Petru Poni” Institute of Macromolecular Chemistry, Romanian Academy, where he specialized in polymeric drug delivery systems and hydrogel design. His academic background provided a strong foundation in both the theoretical and practical aspects of macromolecular chemistry and biomedical applications. Dr. Fundueanu has further enriched his expertise through postdoctoral fellowships and collaborative research programs across Europe, focusing on biomaterials, pharmacokinetics, and advanced polymer synthesis for medical applications.

Experience 

Dr. Fundueanu has held leading roles in polymer research. As Head of the Department of Natural Polymers, Bioactive and Biocompatible Materials at the “Petru Poni” Institute, he has supervised numerous national and European research projects. His expertise spans polymer synthesis, hydrogel engineering, drug delivery systems, and biomedical testing. He has collaborated extensively with pharmaceutical and academic institutions, contributing to translational research in bioactive materials. His interdisciplinary work involves analytical chemistry, cell culture methodologies, and regulatory aspects of biocompatibility testing. Dr. Fundueanu has also mentored students and postdoctoral fellows in advanced materials science.

Awards and Honors 

Dr. Gheorghe Fundueanu has received multiple honors for his significant contributions to macromolecular chemistry and biomedical applications. He was awarded the “Gheorghe Spacu” Prize by the Romanian Academy and recognized by the Ministry of Education and Research for excellence in scientific innovation. He has also received accolades at national conferences and international symposia for his work in polymer-based drug delivery systems. His research has been repeatedly supported by prestigious European funding programs. In addition to his awards, Dr. Fundueanu has served as a peer reviewer for high-impact journals and is a respected figure in Romania’s scientific and academic community.

Research Focus 

Dr. Fundueanu’s research primarily targets the synthesis and characterization of smart polymeric materials tailored for biomedical applications. His work emphasizes drug delivery systems based on natural and synthetic polymers, with a special interest in biomimetic hydrogels that mimic extracellular matrices. He investigates the in vitro and in vivo behavior of these materials to evaluate their biocompatibility and therapeutic performance. His studies also include protocols for pharmaceutical analysis in biological media, ensuring precision in dosage and release kinetics. By bridging polymer science with pharmacological applications, his research supports innovations in personalized medicine, regenerative therapies, and advanced drug formulations.

Publication Top Notes

Physico-chemical characterization of Ca-alginate microparticles produced with different methods
Cited by: 383 | Year: 1999

Preparation and characterization of pH-and temperature-sensitive pullulan microspheres for controlled release of drugs
G Fundueanu, M Constantin, P Ascenzi
Cited by: 222 | Year: 2008

Removal of anionic dyes from aqueous solutions by an ion-exchanger based on pullulan microspheres
Cited by: 152 | Year: 2013

Preparation and characterization of Ca-alginate microspheres by a new emulsification method
Cited by: 135 | Year: 1998

Poly(N-isopropylacrylamide-co-acrylamide) cross-linked thermoresponsive microspheres obtained from preformed polymers: influence of the physico-chemical characteristics
Cited by: 125 | Year: 2009

Lower critical solution temperature versus volume phase transition temperature in thermoresponsive drug delivery systems
Cited by: 123 | Year: 2011

Preparation and characterisation of poly(vinyl alcohol)/cyclodextrin microspheres as matrix for inclusion and separation of drugs
Cited by: 100 | Year: 2004

Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy) in allergic rhinitis treatment
Cited by: 98 | Year: 2004

Dual cross-linked chitosan/PVA hydrogels containing silver nanoparticles with antimicrobial properties
Cited by: 97 | Year: 2021

Cellulose acetate butyrate microcapsules containing dextran ion-exchange resins as self-propelled drug release system
Cited by: 94 | Year: 2005

Poly(N-isopropylacrylamide-co-methacrylic acid) pH/thermo-responsive porous hydrogels as self-regulated drug delivery system
Cited by: 91 | Year: 2014

Smart composite materials based on chitosan microspheres embedded in thermosensitive hydrogel for controlled delivery of drugs
Cited by: 89 | Year: 2017

Novel biodegradable flocculanting agents based on pullulan
Cited by: 81 | Year: 2010

Conclusion

Dr. Gheorghe Fundueanu’s distinguished career, groundbreaking contributions to polymeric biomaterials and drug delivery systems, and his leadership in biomedical research position him as a strong and deserving nominee for the Best Researcher Award. His work not only advances scientific understanding but also holds immense promise for future therapeutic applications.

Cheng Li | Drug Delivery Systems | Best Researcher Award

Prof. Cheng Li | Drug Delivery Systems | Best Researcher Award

Profess at Shanghai Fourth People’s Hospital | School of Medicine | Tongji Universit | China

Prof. Cheng Li  is a distinguished chief physician, professor, and doctoral supervisor in anesthesiology. A visiting scholar at Harvard University , he directs a National Key Clinical Specialty and serves as a leading researcher at the Shanghai Key Laboratory of Anesthesia and Brain Function Regulation . Prof. Li has pioneered 11 innovative technologies enhancing elderly critical care and brain protection . His prolific academic, clinical, and mentorship contributions have earned him national recognition . Dedicated to advancing anesthesia and perioperative science, Prof. Li is shaping the future of surgical medicine through groundbreaking innovation and academic excellence.

Profile 

Scopus

Education

Prof. Cheng Li completed his medical education from top-tier Chinese medical institutions . His rigorous academic training in anesthesiology and perioperative medicine laid the foundation for his specialization in critical care for elderly patients and neurological function regulation . He further enhanced his expertise as a visiting scholar at Harvard University , gaining international exposure and experience. As a committed academician, he continues to mentor postgraduate and doctoral students . Prof. Li’s comprehensive education, both domestic and abroad, has equipped him with deep clinical insight, strong research methodology skills, and a global perspective on patient care .

Experience 

Prof. Li Cheng has over two decades of clinical and research experience in anesthesiology and perioperative medicine . He serves as the Director of a National Key Clinical Specialty and leads a research team at the Shanghai Key Laboratory of Anesthesia and Brain Function Regulation . He is actively involved in hospital technology adoption and has led the development of 11 technologies for elderly and critically ill patients . Prof. Li holds more than 20 academic positions and has supervised 24 postdoctoral, Ph.D., and master’s students . He continues to impact both policy and practice in Chinese medical institutions .

Awards 

Prof. Cheng Li has received numerous prestigious awards recognizing his academic and clinical excellence. These include Shanghai Outstanding Academic Leader, Shanghai Young Top Talent, and the Third Prize of the Shanghai Silver Snake Award. He was named “China’s Good Doctor”, the First Shanghai Good Doctor, and received the Outstanding Young Medical Talent – “Medical Star of Shanghai”. In 2022, he was honored as the “Outstanding Teacher of the Most Beautiful Professional Ethics” by Tongji University. His team has earned collective honors such as the Advanced Collective of the National Health and Wellness System.

Research Focus 

Prof. Li’s research is centered on anesthesia and perioperative management in elderly and critically ill patients. His work on brain protection and neurological regulation has led to 11 innovative clinical technologies. He is actively exploring biomarker-based monitoring, neuro-anesthetic pharmacology, and personalized anesthesia protocols in surgical settings. His involvement in intraoperative brain function control, post-operative cognitive disorder prevention, and advanced anesthesia devices underscores his commitment to translational medicine. Prof. Li’s research integrates clinical expertise with cutting-edge science to elevate surgical safety and efficiency, especially for high-risk elderly patients.

Publication Top Notes

Title: Three-stage sequential targeted nasal drops for correcting abnormal mitochondrial division in microglia
Journal: Bioactive Materials
Year: 2025

Title: Lactate inhibits T-cell activation in sepsis through CD40LG downregulation and SOCS3-mediated JAK1/STAT3 pathway suppression
Journal: Biochimica et Biophysica Acta – Molecular Basis of Disease
Year: 2025

Title: Clinical biomarkers of perioperative neurocognitive disorder: initiation and recommendation
Journal: [Journal name not specified]
Year: 2025
Cited by: 1

Title: Thermo-responsive and biodegradable MoS2-based nanoplatform for tumor therapy and postoperative wound management
Journal: Journal of Colloid and Interface Science
Year: 2025
Cited by: 2

Title: Disrupting the activity of endogenous gas neurotransmitters: a therapeutic strategy using engineered metal–organic frameworks for cancer
Journal: Medical Gas Research
Year: 2025

Conclusion

In conclusion, Prof. Cheng Li’s impactful innovations, prolific research output, and exceptional leadership in anesthesiology make him a highly deserving candidate for the Best Researcher Award. His clinical and academic contributions have significantly advanced patient care and scientific knowledge in anesthesiology, earning national recognition and academic prestige. With ongoing focus and minor enhancements in international outreach and interdisciplinary integration, he stands poised to further shape the global landscape of perioperative and critical care research.